[Federal Register Volume 82, Number 53 (Tuesday, March 21, 2017)]
[Page 14520]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05486]



National Institutes of Health

Eunice Kennedy Shrive National Institute of Child Health and 
Human Development; Notice of Committee Establishment

    Pursuant to the Federal Advisory Committee Act, as amended (5 
U.S.C. App.), the Director, National Institutes of Health (NIH), 
announces the establishment of the Task Force on Research Specific to 
Pregnant Women and Lactating Women (Task Force) as required by section 
2041 of the 21st Century Cures Act, Public Law 114-255.
    The Task Force will provide advice and guidance to the Secretary, 
Department of Health and Human Services (Secretary), regarding Federal 
activities related to identifying and addressing gaps in knowledge and 
research regarding safe and effective therapies for pregnant women and 
lactating women, including the development of such therapies and the 
collaboration on and coordination of such activities. The Task Force 
will, not later than 18 months after the establishment, prepare and 
submit a report to the Secretary, the Committee on Health, Education, 
Labor and Pensions of the Senate, and the Committee on Energy and 
Commerce of the House of Representatives.
    It is determined that the Task Force is in the public interest in 
connection with the performance of duties imposed on the NIH by 
statute, and that these duties can best be performed through the advice 
and counsel of this group.
    Inquiries may be directed to Jennifer Spaeth, Director, Office of 
Federal Advisory Committee Policy, Office of the Director, National 
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, 
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or 
[email protected].

    Dated: March 15, 2017.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-05486 Filed 3-20-17; 8:45 am]